ATE149163T1 - Indolin derivate als 5ht2c antagonisten - Google Patents

Indolin derivate als 5ht2c antagonisten

Info

Publication number
ATE149163T1
ATE149163T1 AT94921638T AT94921638T ATE149163T1 AT E149163 T1 ATE149163 T1 AT E149163T1 AT 94921638 T AT94921638 T AT 94921638T AT 94921638 T AT94921638 T AT 94921638T AT E149163 T1 ATE149163 T1 AT E149163T1
Authority
AT
Austria
Prior art keywords
indoline derivatives
5ht2c
antagonists
5ht2c antagonists
indoline
Prior art date
Application number
AT94921638T
Other languages
German (de)
English (en)
Inventor
Peter Ham
Graham Elgin Jones
Ian Thomson Forbes
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of ATE149163T1 publication Critical patent/ATE149163T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Eyeglasses (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT94921638T 1993-07-06 1994-06-30 Indolin derivate als 5ht2c antagonisten ATE149163T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939313913A GB9313913D0 (en) 1993-07-06 1993-07-06 Novel compounds

Publications (1)

Publication Number Publication Date
ATE149163T1 true ATE149163T1 (de) 1997-03-15

Family

ID=10738344

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94921638T ATE149163T1 (de) 1993-07-06 1994-06-30 Indolin derivate als 5ht2c antagonisten

Country Status (15)

Country Link
US (1) US5834494A (OSRAM)
EP (1) EP0707581B1 (OSRAM)
JP (1) JPH08512299A (OSRAM)
CN (1) CN1129937A (OSRAM)
AP (1) AP463A (OSRAM)
AT (1) ATE149163T1 (OSRAM)
AU (1) AU7228394A (OSRAM)
CA (1) CA2166624A1 (OSRAM)
DE (1) DE69401823T2 (OSRAM)
GB (1) GB9313913D0 (OSRAM)
IL (1) IL110204A0 (OSRAM)
MA (1) MA23254A1 (OSRAM)
TW (1) TW297023B (OSRAM)
WO (1) WO1995001976A1 (OSRAM)
ZA (1) ZA944807B (OSRAM)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618824A (en) * 1994-03-09 1997-04-08 Merrell Pharmaceuticals Inc. Treatment of obsessive-compulsive disorders with 5-HT2 antagonists
GB9414139D0 (en) * 1994-07-13 1994-08-31 Smithkline Beecham Plc Novel compounds
GB9420521D0 (en) * 1994-10-12 1994-11-30 Smithkline Beecham Plc Novel compounds
BR9607016A (pt) * 1995-02-02 1997-10-28 Smithkline Beecham Plc Derivados de indol como antagonísta de receptor 5-ht
WO1996023769A2 (en) * 1995-02-02 1996-08-08 Smithkline Beecham Plc Heterocyclic compounds possessing 5ht2c receptor antagonist activity
GB9517559D0 (en) * 1995-08-26 1995-10-25 Smithkline Beecham Plc Novel compounds
CA2253941A1 (en) * 1996-05-16 1997-11-20 Sumanas Rakhit Thiophene- and furan-tryptamine derivatives
GB9612883D0 (en) * 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
GB9612885D0 (en) * 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
US6362009B1 (en) 1997-11-21 2002-03-26 Merck & Co., Inc. Solid phase synthesis of heterocycles
FR2778662B1 (fr) * 1998-05-12 2000-06-16 Adir Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1122252A4 (en) * 1998-10-16 2002-06-26 Takeda Chemical Industries Ltd CONDENSED HEREROCYCLIC NITROGEN COMPOUNDS; MANUFACTURING PROCESS AND AGENTS CONTAINING THEM
US6453357B1 (en) 1999-01-07 2002-09-17 Cisco Technology, Inc. Method and system for processing fragments and their out-of-order delivery during address translation
US6465467B1 (en) 1999-05-21 2002-10-15 Biovitrum Ab Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
ES2252004T3 (es) * 1999-05-21 2006-05-16 Biovitrum Ab Nuevos compuestos, su uso y preparacion.
UA77650C2 (en) 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
FR2810979B1 (fr) * 2000-06-29 2002-08-23 Adir Nouveaux derives de diphenyluree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB0019950D0 (en) * 2000-08-12 2000-09-27 Smithkline Beecham Plc Compounds
SE0004245D0 (sv) 2000-11-20 2000-11-20 Pharmacia Ab Novel compounds and their use
EP1304589A1 (en) * 2001-07-09 2003-04-23 Alcatel Connector for optical fibers
US6861440B2 (en) 2001-10-26 2005-03-01 Hoffmann-La Roche Inc. DPP IV inhibitors
FR2837823B1 (fr) * 2002-03-27 2005-04-08 Servier Lab Nouveaux derives d'indoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
NZ536664A (en) 2002-06-19 2007-07-27 Biovitrum Ab Piperazinylpyrazine derivative compounds, their use and preparation
BRPI0411509A (pt) 2003-06-20 2006-07-25 Hoffmann La Roche compostos, processo para a sua manufatura, composições farmacêuticas que compreendem os mesmos, método para tratamento e/ou profilaxia de enfermidades que estão associadas com dpp-iv e sua utilização
EA009591B1 (ru) 2003-06-20 2008-02-28 Ф.Хоффманн-Ля Рош Аг Производные пиридо[2,1-а]изохинолина в качестве ингибиторов dpp-iv
AR058040A1 (es) * 2005-09-13 2008-01-23 Bayer Cropscience Ag Derivados plaguicidas de fenilamidina sustituida con feniloxi
US8293100B2 (en) 2009-03-13 2012-10-23 Terrasep, Llc Methods and apparatus for centrifugal liquid chromatography
CN106278987A (zh) * 2016-08-16 2017-01-04 都创(上海)医药科技有限公司 吲哚啉类化合物的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4428881A (en) * 1977-12-23 1984-01-31 Gulf Oil Corporation Control of unwanted vegetation with N-carbamylindolines
KR930702334A (ko) * 1990-09-13 1993-09-08 데이비드 로버트 5 하이드록시트립타민 수용체 길항제로서의 인돌우레아
CA2142721A1 (en) * 1992-08-20 1994-03-03 Ian T. Forbes Condensed indole derivatives as 5ht and 5ht antagonists

Also Published As

Publication number Publication date
DE69401823D1 (de) 1997-04-03
EP0707581A1 (en) 1996-04-24
TW297023B (OSRAM) 1997-02-01
AP9400653A0 (en) 1994-07-31
WO1995001976A1 (en) 1995-01-19
AU7228394A (en) 1995-02-06
JPH08512299A (ja) 1996-12-24
US5834494A (en) 1998-11-10
IL110204A0 (en) 1995-01-24
CA2166624A1 (en) 1995-01-19
GB9313913D0 (en) 1993-08-18
DE69401823T2 (de) 1997-08-28
ZA944807B (en) 1996-01-04
EP0707581B1 (en) 1997-02-26
CN1129937A (zh) 1996-08-28
AP463A (en) 1996-02-19
MA23254A1 (fr) 1995-04-01

Similar Documents

Publication Publication Date Title
DE69401823D1 (de) Indolin derivate als 5ht2c antagonisten
DE69605430D1 (de) Chinolin-2-on derivate als serotonin antagonisten
DE69723446D1 (de) Oxindole derivate
FI944969A7 (fi) Indolijohdannaisia
DE69712331D1 (de) Pyrimidin-4-on derivate als pestizidesmittel
FI931558A7 (fi) Indolin johdannaisia
ATE180785T1 (de) Kondensierte indol-derivate als 5-ht4-rezeptor- antagonisten
FI944805A7 (fi) Indolijohdannaisia 5-HT1-kaltaisina agonisteina
FI960840A7 (fi) Indolijohdannaisia tromboksaani-A2-antagonisteina
NO961475L (no) Indol-derivater
FI962969L (fi) Indolijohdannaisia 5-HT1:n agonisteina
NO974043D0 (no) Indolderivater som EAA-antagonister
FI951546L (fi) Parantunut indolin biosynteesi
DE69703242D1 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten
FI944727L (fi) Indolijohdannaisia 5-HT1:n kaltaisina agonisteina
FI950568L (fi) 5-heteroaryyli-indolijohdannaiset
FI943808L (fi) Triatsolopyrimidiinijohdannaisia angiotensiini II:n reseptoreiden vastavaikuttajina
DE69717449D1 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten
DE69320653D1 (de) Tetrahydrocarbazolderivate als 5-ht1-ähnliche agonisten
FI971492L (fi) Indolijohdannaiset 5-HT1-tyyppisinä agonisteina
DE69617010D1 (de) Isazole derivate als fibrinogen-rezeptor-antagonisten
ATE193701T1 (de) Substituierte indol-derivate
ATE210117T1 (de) Indolderivate als melatoninanaloge
FI941118A0 (fi) Bentsyyli-imidatsopyridiinijohdannainen angiotensiini II reseptoriantagonistina
FI941117A0 (fi) Bentsyyli-imidatsopyridiinijohdannaiset angiotensiini II reseptoriantagonisteina

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties